Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-01-10
DOI
10.3389/fmicb.2017.02644
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus
- (2017) Petraleigh Pantoja et al. Nature Communications
- Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies
- (2016) Niyati Khetarpal et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
- (2016) Ankur Poddar et al. BMC BIOTECHNOLOGY
- Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
- (2016) Neil M. Ferguson et al. SCIENCE
- Protective and immunological behavior of chimeric yellow fever dengue vaccine
- (2016) Scott B. Halstead et al. VACCINE
- Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site
- (2015) Scott A. Smith et al. JOURNAL OF VIROLOGY
- Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice
- (2015) Satoru Watanabe et al. JOURNAL OF VIROLOGY
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Next generation dengue vaccines: A review of the preclinical development pipeline
- (2015) Kirsten S. Vannice et al. VACCINE
- Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cells
- (2015) Amporn Suphatrakul et al. VACCINE
- Preclinical and clinical development of a dengue recombinant subunit vaccine
- (2015) Susan B. Manoff et al. VACCINE
- Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies
- (2015) Lav Tripathi et al. Frontiers in Microbiology
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera
- (2014) Ruklanthi de Alwis et al. PLoS Pathogens
- Functional Analysis of Antibodies against Dengue Virus Type 4 Reveals Strain-Dependent Epitope Exposure That Impacts Neutralization and Protection
- (2013) S. Sukupolvi-Petty et al. JOURNAL OF VIROLOGY
- Dengue vaccine efficacy trial: does interference cause failure?
- (2013) Sathyamangalam Swaminathan et al. LANCET INFECTIOUS DISEASES
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
- (2013) Shailendra Mani et al. PLoS One
- The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
- (2013) S. A. Smith et al. mBio
- The Economic Burden of Dengue
- (2012) Duane J. Gubler AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Unique challenges faced by the clinical evaluation of dengue vaccines
- (2011) Robert Edelman Expert Review of Vaccines
- The Necessity and Quandaries of Dengue Vaccine Development
- (2011) S. J. Thomas JOURNAL OF INFECTIOUS DISEASES
- A highly sensitive and specific time resolved fluorometric bridge assay for antibodies to HIV-1 and -2
- (2011) Sheikh M. Talha et al. JOURNAL OF VIROLOGICAL METHODS
- Persistence of Circulating Memory B Cell Clones with Potential for Dengue Virus Disease Enhancement for Decades following Infection
- (2011) S. A. Smith et al. JOURNAL OF VIROLOGY
- In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
- (2011) Ruklanthi de Alwis et al. PLoS Neglected Tropical Diseases
- Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease
- (2010) Raphaël M. Zellweger et al. Cell Host & Microbe
- Evaluation of Extracellular Subviral Particles of Dengue Virus Type 2 and Japanese Encephalitis Virus Produced by Spodoptera frugiperda Cells for Use as Vaccine and Diagnostic Antigens
- (2010) M. Kuwahara et al. Clinical and Vaccine Immunology
- Dengue vaccines: state of the art
- (2010) Sathyamangalam Swaminathan et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris
- (2010) Gaurav Batra et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
- (2010) James D. Brien et al. JOURNAL OF VIROLOGY
- Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2
- (2010) S. Sukupolvi-Petty et al. JOURNAL OF VIROLOGY
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- Immature Dengue Virus: A Veiled Pathogen?
- (2010) Izabela A. Rodenhuis-Zybert et al. PLoS Pathogens
- Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
- (2010) Wahala M. P. B. Wahala et al. PLoS Pathogens
- The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
- (2010) Bimmi Shrestha et al. PLoS Pathogens
- Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
- (2010) Scott J. Balsitis et al. PLoS Pathogens
- Dengue Virus Pathogenesis: an Integrated View
- (2009) B. E. E. Martina et al. CLINICAL MICROBIOLOGY REVIEWS
- Efficient Assembly and Secretion of Recombinant Subviral Particles of the Four Dengue Serotypes Using Native prM and E Proteins
- (2009) Pei-Gang Wang et al. PLoS One
- Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties
- (2009) Wenquan Liu et al. VIRUS GENES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More